Craft
  • Home
  •  / Fate Therapeutics
Fate Therapeutics

Fate Therapeutics

Revenue

$55.8 M

FY, 2021

Market Capitalization

$2.4 B

2022-09-19

Fate Therapeutics Summary

Company summary

Overview
Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. The Company's pipeline is comprised of cell-based therapies for cancer and immune disorders. Its cellular immunotherapies are based on ex vivo cell programming approach to modulate the therapeutic function and direct the fate of hematopoietic cells.
Type
Public
Founded
2007
HQ
San Diego, CA, US | view all locations
Website
http://www.fatetherapeutics.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Scott Wolchko

    Scott Wolchko, President and Chief Executive Officer, Director

  • William Rastetter, Chairman

    • John Mendlein, Vice Chairman

      • Edward Dulac

        Edward Dulac, Chief Financial Officer

      LocationsView all

      2 locations detected

      • San Diego, CA HQ

        United States

        3535 General Atomics Ct

      • San Diego, CA

        United States

        12278 Scripps Summit Dr

      Fate Therapeutics Financials

      Summary financials

      Footer menu